RP Cure Tracker

Trials / NCT02140164

Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa

Completed Phase 1 / Phase 2 Drug / neuroprotection

Sponsor
National Eye Institute (NEI)
Treatment
Minocycline
Gene
Not stated
Conditions
Retinitis Pigmentosa
Ages
12 Years to no upper limit
Enrollment
7 participants
Started
2014-05
Main results expected
2015-11
Results posted
Yes
Record last updated
2024-04-17

What the study is testing

Background:

- Some people with retinitis pigmentosa (RP) have macular edema (swelling) in the central retina. This can cause decreased central vision. The cause of macular edema is unknown, but may involve inflammation. The drug minocycline might help prevent inflammation and therefore might help treat macular edema and improve central visual function .

Objectives:

- To see if minocycline helps people with RP and macular edema.

Eligibility:

- People 12 years and older with RP who have macular edema in at least on eye.

Design:

At each study visit, participants will have some or all of the following tests:

Where it runs

United States (1)

Open on ClinicalTrials.gov for contacts and eligibility